Psoriatic Arthritis

>

On the HCPLive psoriatic arthritis page, resources on the topics of medical news and expert insight into PsA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on arthritis, and more.

Latest News

Tildrakizumab Significantly Improves Skin Symptoms in Moderate-to-Severe Psoriasis
Tildrakizumab Significantly Improves Skin Symptoms in Moderate-to-Severe Psoriasis

March 28th 2024

At week 52, investigators noted an overall improvement of 93% in PASI scores from baseline.

Vibeke Strand, MD | Credit: Prime Education
Deucravacitinib Improves Patient-Reported Outcomes in Active Psoriatic Arthritis

March 27th 2024

Impact of TNFi, IL-17Ai Treatments on Psoriatic Arthritis Biomarkers
Impact of TNFi, IL-17Ai Treatments on Psoriatic Arthritis Biomarkers

March 27th 2024

Bimekizumab Demonstrates Similar, Greater Efficacy Compared with Guselkumab in PsA
Bimekizumab Demonstrates Similar, Greater Efficacy Compared with Guselkumab in PsA

March 27th 2024

Greater Diagnostic Delays Observed in PsA Compared with RA
Greater Diagnostic Delays Observed in PsA Compared with RA

March 26th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.